SUGAR LAND--January 28, 2013--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Despite a prevailing economic pessimism, life science planners are proving to be a rather optimistic bunch. In North America alone, there are currently 264 projects representing a total investment value (TIV) of $21.6 billion in active development. Drawn from reported projects with a future kick-off date from Industrial Info's Pharmaceutical Tracker - Online Database , all are in various stages of planning, ranging from early market analysis to detailed engineering. Other companies featured: Baxter International Corporation (NYSE:BAX) , Johnson & Johnson (NYSE:JNJ)